KLDO insider filings

Kaleido Biosciences, Inc. — 29 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-03-02. Screen KLDO transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for KLDO between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Kaleido Biosciences, Inc.

FiledFormInsiderReported transactionsSource
2022-03-024van Hylckama Vlieg Johan — Chief Scientific OfficerTax withholding (F): 2,087 @ $1.49EDGAR
2022-03-024Korn Jerald — COO & General CounselTax withholding (F): 2,046 @ $1.49EDGAR
2022-01-184van Hylckama Vlieg Johan — Chief Scientific OfficerGrant/award (A): 350,000 (derivative) @ $0EDGAR
2022-01-184Long Alison S — Chief Medical OfficerGrant/award (A): 46,800 (derivative) @ $0 · Grant/award (A): 125,000 (derivative) @ $0EDGAR
2022-01-184Korn Jerald — COO & General CounselGrant/award (A): 45,240 (derivative) @ $0 · Grant/award (A): 250,000 (derivative) @ $0EDGAR
2022-01-184Duke William E. — Chief Financial OfficerGrant/award (A): 44,990 (derivative) @ $0 · Grant/award (A): 125,000 (derivative) @ $0EDGAR
2022-01-184Menichella Daniel L — Chief Executive Officer, DirectorGrant/award (A): 70,200 (derivative) @ $0 · Grant/award (A): 250,000 (derivative) @ $0EDGAR
2021-12-164Long Alison S — Chief Medical OfficerGrant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 24,350 (derivative) @ $0EDGAR
2021-09-024van Hylckama Vlieg Johan — Chief Scientific OfficerGrant/award (A): 40,000 (derivative) @ $0EDGAR
2021-09-024Korn Jerald — General CounselGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-09-024Duke William E. — Chief Financial OfficerGrant/award (A): 60,000 (derivative) @ $0EDGAR
2021-09-024Menichella Daniel L — Chief Executive Officer, DirectorGrant/award (A): 110,000 (derivative) @ $0EDGAR
2021-07-014von Maltzahn Geoffrey — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-07-014Burnett Grady — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-07-014Prener Anne — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-07-014Bassler Bonnie L — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-07-014Mixer Jean K — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-07-014Quinn Anthony G. — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-07-014BONNEY MICHAEL W — DirectorGrant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-07-014MELAS KYRIAZI THEO — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-03-024Korn Jerald — General CounselGrant/award (A): 60,000 (derivative) @ $0EDGAR
2021-03-024Duke William E. — Chief Financial OfficerGrant/award (A): 60,000 (derivative) @ $0EDGAR
2021-03-024Menichella Daniel L — Chief Executive Officer, DirectorGrant/award (A): 90,000 (derivative) @ $0EDGAR
2021-02-264Menichella Daniel L — Chief Executive Officer, DirectorPurchase (P): 20,000 @ $11.50EDGAR
2021-02-104Flagship Ventures Fund IV General Partner LLC — 10% owner
Flagship Ventures Fund IV, L.P. — 10% owner
Flagship Ventures Opportunities Fund I General Partner LLC — 10% owner
Flagship Ventures Opportunities Fund I, L.P. — 10% owner
Nutritional Health LTP Fund General Partner LLC — 10% owner
Nutritional Health LTP Fund, L.P. — 10% owner
AFEYAN NOUBAR — 10% owner
Purchase (P): 71,666 @ $11.50 · Purchase (P): 71,667 @ $11.50 · Purchase (P): 71,667 @ $11.50EDGAR
2020-10-194Korn Jerald — General CounselGrant/award (A): 45,000 (derivative) @ $0EDGAR
2020-10-194Knobil Katharine — Chief Medical OfficerGrant/award (A): 67,500 (derivative) @ $0EDGAR
2020-10-194Duke William E. — Chief Financial OfficerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2020-10-194Menichella Daniel L — Chief Executive Officer, DirectorGrant/award (A): 600,000 (derivative) @ $0EDGAR

Recent 8-K events — Kaleido Biosciences, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2022-04-088-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-03-178-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2022-03-098-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2022-01-288-K8.01 — Other EventsEDGAR
2021-11-018-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-10-058-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2021-09-038-K8.01 — Other EventsEDGAR
2021-08-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-08-098-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2021-07-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=KLDO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs